Long-Term Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin As Intensification Therapies For People With Type 2 Diabetes Inadequately Controlled on Basal Insulin In Spain- Projections Based On The Dual VII Trial
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.461
https://www.valueinhealthjournal.com/article/S1098-3015(17)30795-7/fulltext
Title :
Long-Term Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin As Intensification Therapies For People With Type 2 Diabetes Inadequately Controlled on Basal Insulin In Spain- Projections Based On The Dual VII Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30795-7&doi=10.1016/j.jval.2017.08.461
First page :
A480
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
438